Glattpark (Opfikon), 29 June 2026 – As part of the West Link (Västlänken) project in Gothenburg, the Swedish Transport Administration (Trafikverket) is awarding the execution contract for “E16 Korsvägen station“ to Implenia. The contract is worth more than CHF 250 million in a cost-plus reimburseme…
Altra Fastigheter AB ("Altra") has entered into an agreement to divest four properties at an agreed property value of SEK 1,187 million, before deduction for deferred tax of SEK 40 million. The transaction is conditional upon the buyer, Storsala AB (publ), entering into final loan documentation for…
STOCKHOLM (dpa-AFX) - Swedish Orphan Biovitrum AB (SWOBY) on Friday announced that the U.S. Food and Drug Administration has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for NASP (nanoencapsulated sirolimus plus pegadricase) for the treatment of adult patients…
STOCKHOLM, June 26, 2026 /PRNewswire/ --The FDA has requested additional data related to chemistry, manufacturing, and controls (CMC) and contract manufacturing facilities; no clinical safety or efficacy concerns were identified that impact approvabilitySobi to meet with FDA to discuss next steps f…
The U.S. Food and Drug Administration declined to approve Swedish drugmaker Sobi's OMXSTO:SOBI therapy to treat uncontrolled gout, a common form of inflammatory arthritis, the company said on Friday.In its so-called complete response letter, the FDA asked the company to provide more data, mainly re…
Swedish Orphan Biovitrum AB (publ) OMXSTO:SOBI:
The U.S. Food and Drug Administration declined to approve Swedish drugmaker Sobi's OMXSTO:SOBI therapy to treat uncontrolled gout, a common form of inflammatory arthritis, the company said on Friday.
